SPEAKERS Abbas Walji Senior Director, Discovery Chemistry Merck Cameron Pye Chief Executive Officer Unnatural Products Christian Cunningham Chief Scientific Officer PeptiDream Inc. David Brayden Full Professor, Advanced Drug Delivery University College Dublin Dehua Pei Professor Ohio State University Emel Adaligil Principal Manager - Scientific Peptide Therapeutics Genentech James Bowman Director AI Proteins Jeffrey Schubert Principal Scientist Merck John Tan Director, Informatics Nimble Therapeutics Joshua Schwochert Co-founder & Chief Scientific Officer Unnatural Products Laura Nevola Co-Founder, Chief Scientific Officer & Chief Operating Officer IDP Pharma Lauren Goodrich-Berto Vice President - Therapeutic Discovery Nimble Therapeutics Inc. Manuel Sanchez-Felix Vice President - Drug Delivery Search & Evaluation Halozyme Therapeutics Markus Haeberlein Vice President - Discovery Science Executive Parabilis Medicines Matt Streeter Senior Scientist - Discovery Chemistry Entrada Therapeutics Inc. Meritxell teixido tura CEo and Cofounder Gate2Brain S.L. Miriam Kidron CSO Oramed Pharmaceuticals Patrick Salveson Co-founder & Chief Technology Officer Vilya Pete Gough Chief Scientific Officer Nimble Therapeutics Ranganath gopalakrishnan Director, CVRM New Modalities AstraZeneca Rick Ewing Vice President & Head of Chemistry Rapafusyn Pharmaceuticals Sevan Habeshian Co-founder & Chief Technology Officer Orbis Medicines Thomas Von Erlach Co-Founder & Chief Scientific Officer Vivtex Tina Boville Co-founder & Chief Executive Officer Aralez Bio Toby Passioura Co-Founder & Chief Scientific Officer Insamo Biotech Tomi Sawyer Chief Drug Hunter & President Maestro Therapeutics Xavier Michelet Senior Investigator, Director & Head of Pharmacology & Biology AI Proteins Yoshihisa Murata Head of Advanced Computational Chemistry Group Chugai Pharmaceutical Co Yu-Shan Lin Professor and Department Chair of Chemistry Tufts University